Matthew C Abramowitz MD

Radiation Oncology•Miami, FL

Central Nervous System Cancer, Head & Neck, Urologic Cancer

Associate Professor, Radiation Oncology, University of Miami School of Medicine

Join to View Full Profile

1475 Nw 12th AveSuite 1500Miami, FL 33136
Phone+1 305-243-4200
Fax+1 305-243-4363

Education & Training

Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2004 - 2008
Crozer-Chester Medical CenterInternship, Transitional Year, 2003 - 2004
Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

FL State Medical License 2008 - 2026
PA State Medical License 2003 - 2014
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Start of enrollment: 2011 Oct 31
Completed
Not Applicable
MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Start of enrollment: 2012 Jul 12
ACTIVE_NOT_RECRUITING
NA
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) for Prostate Cancer Start of enrollment: 2013 Apr 04
RECRUITING
NA
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Start of enrollment: 2013 Jun 03
Terminated
Phase 2
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
Withdrawn
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Start of enrollment: 2016 Jan 05
Terminated
Not Applicable
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy Start of enrollment: 2015 Feb 05
ACTIVE_NOT_RECRUITING
NA
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma Start of enrollment: 2022 Sep 21
RECRUITING
NA
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Rando...
Jarey H Wang, Alexander D Sherry, Soha Bazyar, Philip Sutera, Noura Radwan
Journal of Clinical Oncology. 2025-06-20
Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.
Jonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, Kaylie Cullison, Gregory A Azzam
Radiation Oncology. 2025-05-22
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.
Isabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, Adrian L Breto, Ahmad Algohary
Academic Radiology. 2025-04-01

Press Mentions

New Prostate Cancer Test Pinpoints Disease Better Than PSA Option, Study FindsMay 1st, 2025
A Phase III Randomized Trial of MRI-Mapped, Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS TrialJune 28th, 2015
$Radiation Hypofractionation via Extended Versus Accelerated Therapy (HEAT) for Prostate Cancer (HEAT)$
Radiation Hypofractionation via Extended Versus Accelerated Therapy (HEAT) for Prostate Cancer (HEAT)February 18th, 2013